Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Journal: Journal of the American Heart Association
Published: October 07, 2022
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Journal: Thrombosis and haemostasis
Published: September 25, 2015
Showing 1-2 of 2
Last Updated: 09/26/2026